These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Significance of genome-wide analysis of copy number alterations and UPD in myelodysplastic syndromes using combined CGH - SNP arrays. Ahmad A; Iqbal MA Curr Med Chem; 2012; 19(22):3739-47. PubMed ID: 22680919 [TBL] [Abstract][Full Text] [Related]
23. Genomic analysis of acute myeloid leukemia: potential for new prognostic indicators. Eklund EA Curr Opin Hematol; 2010 Mar; 17(2):75-8. PubMed ID: 20075726 [TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia. Gronseth CM; McElhone SE; Storer BE; Kroeger KA; Sandhu V; Fero ML; Appelbaum FR; Estey EH; Fang M Cancer; 2015 Sep; 121(17):2900-8. PubMed ID: 26033747 [TBL] [Abstract][Full Text] [Related]
25. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11. Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900 [TBL] [Abstract][Full Text] [Related]
26. GAS6 Oncogene and Reverse MLLT3-KMT2A Duplications in an Infant with Acute Myeloid Leukemia and a Novel Complex Hyperdiploid Karyotype: Detailed High-Resolution Molecular Cytogenetic Studies. Capela de Matos RR; Ney Garcia DR; Cifoni E; Othman MAK; Tavares de Souza M; Carboni EK; Ferreira GM; Liehr T; Ribeiro RC; M Silva ML Cytogenet Genome Res; 2017; 152(1):33-37. PubMed ID: 28595195 [TBL] [Abstract][Full Text] [Related]
27. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer. Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676 [TBL] [Abstract][Full Text] [Related]
28. Cytogenetic profile in de novo acute myeloid leukemia with FAB subtypes M0, M1, and M2: a study based on 652 cases analyzed with morphology, cytogenetics, and fluorescence in situ hybridization. Klaus M; Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C Cancer Genet Cytogenet; 2004 Nov; 155(1):47-56. PubMed ID: 15527902 [TBL] [Abstract][Full Text] [Related]
29. Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia. Parkin B; Erba H; Ouillette P; Roulston D; Purkayastha A; Karp J; Talpaz M; Kujawski L; Shakhan S; Li C; Shedden K; Malek SN Blood; 2010 Dec; 116(23):4958-67. PubMed ID: 20729466 [TBL] [Abstract][Full Text] [Related]
30. Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing. Dolnik A; Engelmann JC; Scharfenberger-Schmeer M; Mauch J; Kelkenberg-Schade S; Haldemann B; Fries T; Krönke J; Kühn MW; Paschka P; Kayser S; Wolf S; Gaidzik VI; Schlenk RF; Rücker FG; Döhner H; Lottaz C; Döhner K; Bullinger L Blood; 2012 Nov; 120(18):e83-92. PubMed ID: 22976956 [TBL] [Abstract][Full Text] [Related]
31. Analysis of NUP98/NSD1 translocations in adult AML and MDS patients. Thol F; Kölking B; Hollink IH; Damm F; van den Heuvel-Eibrink MM; Michel Zwaan C; Bug G; Ottmann O; Wagner K; Morgan M; Hofmann WK; Göhring G; Schlegelberger B; Krauter J; Ganser A; Heuser M Leukemia; 2013 Mar; 27(3):750-4. PubMed ID: 22929522 [No Abstract] [Full Text] [Related]
32. Array-based cytogenetic approaches in acute myeloid leukemia: clinical impact and biological insights. Bullinger L; Fröhling S Semin Oncol; 2012 Feb; 39(1):37-46. PubMed ID: 22289490 [TBL] [Abstract][Full Text] [Related]
33. Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype. Yi JH; Huh J; Kim HJ; Kim SH; Kim HJ; Kim YK; Sohn SK; Moon JH; Kim SH; Kim KH; Won JH; Mun YC; Kim H; Park J; Jung CW; Kim DH J Clin Oncol; 2011 Dec; 29(35):4702-8. PubMed ID: 22084373 [TBL] [Abstract][Full Text] [Related]
34. Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype. Haferlach C; Dicker F; Herholz H; Schnittger S; Kern W; Haferlach T Leukemia; 2008 Aug; 22(8):1539-41. PubMed ID: 18528419 [TBL] [Abstract][Full Text] [Related]
35. Presence of copy number aberration and clinical prognostic factors in patients with acute myeloid leukemia: an analysis of effect modification. Bănescu C; Tripon F; Trifa AP; Crauciuc AG; Bogliș A; Lazar E; Dima D; Macarie I; Duicu C; Iancu M Pol Arch Intern Med; 2019 Dec; 129(12):898-906. PubMed ID: 31808755 [TBL] [Abstract][Full Text] [Related]
36. Genetic changes including gene copy number alterations and their relation to prognosis in childhood acute myeloid leukemia. Armengol G; Canellas A; Alvarez Y; Bastida P; Toledo JS; Pérez-Iribarne Mdel M; Camós M; Tuset E; Estella J; Coll MD; Caballín MR; Knuutila S Leuk Lymphoma; 2010 Jan; 51(1):114-24. PubMed ID: 20001230 [TBL] [Abstract][Full Text] [Related]
37. Mutational profiling of acute myeloid leukemia with normal cytogenetics in Brazilian patients: the value of next-generation sequencing for genomic classification. de Noronha TR; Mitne-Neto M; Chauffaille ML J Investig Med; 2017 Dec; 65(8):1155-1158. PubMed ID: 28923882 [TBL] [Abstract][Full Text] [Related]
38. Prognostic implications of gene mutations in acute myeloid leukemia with normal cytogenetics. Gaidzik V; Döhner K Semin Oncol; 2008 Aug; 35(4):346-55. PubMed ID: 18692685 [TBL] [Abstract][Full Text] [Related]
39. Integrated analysis of copy number alteration and RNA expression profiles of cancer using a high-resolution whole-genome oligonucleotide array. Jung SH; Shin SH; Yim SH; Choi HS; Lee SH; Chung YJ Exp Mol Med; 2009 Jul; 41(7):462-70. PubMed ID: 19322034 [TBL] [Abstract][Full Text] [Related]